124 related articles for article (PubMed ID: 24343338)
1. Quantitative assessment of the influence of CYP1B1 polymorphisms and head and neck squamous cell carcinoma risk.
Shen M; Hu YY; Hu YK; Xie LC; Xu XM; Wu MY; Niu YM
Tumour Biol; 2014 Apr; 35(4):3891-7. PubMed ID: 24343338
[TBL] [Abstract][Full Text] [Related]
2. Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.
Teng Y; He C; Zuo X; Li X
Int J Gynecol Cancer; 2013 Mar; 23(3):422-30. PubMed ID: 23370603
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer.
Singh AP; Shah PP; Mathur N; Buters JT; Pant MC; Parmar D
Mutat Res; 2008 Mar; 639(1-2):11-9. PubMed ID: 18067928
[TBL] [Abstract][Full Text] [Related]
4. Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis.
Cui L; Dillehay K; Chen W; Shen D; Dong Z; Li W
Mol Biol Rep; 2012 Jul; 39(7):7465-71. PubMed ID: 22327650
[TBL] [Abstract][Full Text] [Related]
5. The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers.
Liu Y; Lin CS; Zhang AM; Song H; Fan CC
Tumour Biol; 2014 May; 35(5):4719-25. PubMed ID: 24453031
[TBL] [Abstract][Full Text] [Related]
6. Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype.
Jorge-Nebert LF; Zhang G; Wilson KM; Jiang Z; Butler R; Gluckman JL; Pinney SM; Nebert DW
Hum Genomics; 2016 Nov; 10(1):39. PubMed ID: 27894333
[TBL] [Abstract][Full Text] [Related]
7. The CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: evidence from 6501 subjects.
Chen B; Qiu LX; Li Y; Xu W; Wang XL; Zhao WH; Wu JQ
Lung Cancer; 2010 Dec; 70(3):247-52. PubMed ID: 20395011
[TBL] [Abstract][Full Text] [Related]
8. Association of CYP1B1 Leu432Val polymorphism and lung cancer risk: an updated meta-analysis.
Lao X; Qin X; Peng Q; Chen Z; Lu Y; Liu Y; Li S
Lung; 2014 Oct; 192(5):739-48. PubMed ID: 24989113
[TBL] [Abstract][Full Text] [Related]
9. No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.
Yao L; Fang F; Wu Q; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(1):237-42. PubMed ID: 20033481
[TBL] [Abstract][Full Text] [Related]
10. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.
Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T
Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P1B1 (CYP1B1) polymorphisms and ovarian cancer risk: a meta-analysis.
Gajjar K; Owens G; Sperrin M; Martin-Hirsch PL; Martin FL
Toxicology; 2012 Dec; 302(2-3):157-62. PubMed ID: 23032576
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in metabolizing enzymes and the risk of head and neck squamous cell carcinoma in the Slavic population of the central Europe.
Soucek P; Susova S; Mohelnikova-Duchonova B; Gromadzinska J; Moraviec-Sztandera A; Vodicka P; Vodickova L
Neoplasma; 2010; 57(5):415-21. PubMed ID: 20568895
[TBL] [Abstract][Full Text] [Related]
13. CYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis.
Xie Y; Liu GQ; Miao XY; Liu Y; Zhou W; Zhong DW
Tumour Biol; 2012 Jun; 33(3):809-16. PubMed ID: 22190224
[TBL] [Abstract][Full Text] [Related]
14. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair.
Harth V; Schafer M; Abel J; Maintz L; Neuhaus T; Besuden M; Primke R; Wilkesmann A; Thier R; Vetter H; Ko YD; Bruning T; Bolt HM; Ickstadt K
J Toxicol Environ Health A; 2008; 71(13-14):887-97. PubMed ID: 18569591
[TBL] [Abstract][Full Text] [Related]
15. The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density.
Napoli N; Rini GB; Serber D; Giri T; Yarramaneni J; Bucchieri S; Camarda L; Di Fede G; Camarda MR; Jain S; Mumm S; Armamento-Villareal R
Bone; 2009 Mar; 44(3):442-8. PubMed ID: 18977467
[TBL] [Abstract][Full Text] [Related]
16. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
17. Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis.
He XF; Wei J; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ; Liu Q; Wu LX; Wei W
PLoS One; 2014; 9(8):e100487. PubMed ID: 25115775
[TBL] [Abstract][Full Text] [Related]
18. No association between the CYP1B1 C4326G polymorphism and endometrial cancer risk: a meta-analysis.
Wang XW; Chen YL; Luo YL; Liu QY
Asian Pac J Cancer Prev; 2011; 12(9):2343-8. PubMed ID: 22296381
[TBL] [Abstract][Full Text] [Related]
19. Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis.
Xu W; Zhou Y; Hang X; Shen D
Mol Biol Rep; 2012 Mar; 39(3):2821-9. PubMed ID: 21674184
[TBL] [Abstract][Full Text] [Related]
20. COX-2 rs689466, rs5275, and rs20417 polymorphisms and risk of head and neck squamous cell carcinoma: a meta-analysis of adjusted and unadjusted data.
Leng WD; Wen XJ; Kwong JSW; Huang W; Chen JG; Zeng XT
BMC Cancer; 2016 Jul; 16():457. PubMed ID: 27412115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
